Endometrial Ablation Devices Market by Technology Type and End User - Global Opportunity Analysis and Industry Forecast, 2018-2024

  • ID: 4580670
  • Report
  • Region: Global
  • 170 pages
  • Allied Analytics LLP
1 of 4
Endometrial ablation is adopted to remove or destroy the endometrial lining of the uterus for the treatment of heavy menstrual bleeding. Women with heavy menstrual bleeding are prescribed medicines. However, endometrial ablation is performed in case medication fails. This procedure is not recommended for women who wish to conceive.

The endometrial ablation devices market is expected to grow at a significant rate during the forecast period, owing to increase in awareness regarding endometrial ablation technology, increase in prevalence of menorrhagia, and rise in preference for endometrial ablation over the hysterotomy. In addition, technological advancements in endometrial ablation devices and benefits of the endometrial ablation over the surgical procedures further facilitate the growth of the market. However, stringent government regulations for the approval of endometrial ablation devices and risks associated with the use of these devices are expected to impede the market growth. The endometrial ablation devices market generated $882 million in 2017, and is projected to reach $1,299 million by 2024, growing at a CAGR of 5.6% from 2018 to 2024.

The global endometrial ablation devices market is segmented based on technology type, end user, and region. Based on technology type, the market is classified into radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon, hysteroscopic ablation, and others. According to end user, the market is divided into ambulatory surgery center, clinic, and hospitals. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2024, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Technology Type

Radiofrequency Ablation
Cryoablation
Hydrothermal Ablation
Thermal Balloon
Hysteroscopic Ablation
Others

By End User

Ambulatory Surgery Center
Clinic
Hospital

By Region

North America
U.S.
Canada
Mexico

Europe
Germany
France
UK
Italy
Spain
Rest of Europe

Asia-Pacific
Japan
China
Australia
India
South Korea

Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

AEGEA Medical, Inc.
Boston Scientific Corporation
CooperSurgical Inc.
Hologic, Inc.
Idoman Teoranta
Minerva Surgical, Inc.
Olympus Corporation
Omnitech Systems, Inc.
Smith & Nephew plc. (Medtronic plc.)
Veldana Medical SA

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Karl Storz GmbH & Co. KG
Richard Wolf GmbH
AngioDynamics Inc.
Microsulis Americas, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Market Share Analysis
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Benefits of endometrial ablation over hysterectomy
3.3.1.2. Advancement in endometrial ablation techniques
3.3.1.3. High number of menorrhagia affected population
3.3.1.4. Increase in healthcare expenditures worldwide
3.3.2. Restraint
3.3.2.1. Risk associated with endometrial ablation
3.3.3. Opportunities
3.3.3.1. Growth opportunities in emerging markets
3.3.3.2. Increase in demand for minimally invasive procedures
3.3.4. Impact Analyses

CHAPTER 4: ENDOMETRIAL ABLATION DEVICES MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Radiofrequency Ablation
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Cryoablation
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Hydrothermal Ablation
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Thermal Balloon
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Hysteroscopic Ablation
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Others
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country

CHAPTER 5: ENDOMETRIAL ABLATION DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Ambulatory Surgical Center
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Clinics
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Hospitals
5.4.1. Market size and forecast
5.4.2. Market analysis, by country

CHAPTER 6: ENDOMETRIAL ABLATION DEVICES MARKET BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. endometrial ablation devices market, by technology type
6.2.2.1.2. U.S. endometrial ablation devices market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada endometrial ablation devices market, by technology type
6.2.2.2.2. Canada endometrial ablation devices market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico endometrial ablation devices market, by technology type
6.2.2.3.2. Mexico endometrial ablation devices market, by end user
6.2.3. North America endometrial ablation devices market, by technology type
6.2.4. North America endometrial ablation devices market, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany endometrial ablation devices market, by technology type
6.3.2.1.2. Germany endometrial ablation devices market, by end user
6.3.2.2. France
6.3.2.2.1. France endometrial ablation devices market, by technology type
6.3.2.2.2. France endometrial ablation devices market, by end user
6.3.2.3. UK
6.3.2.3.1. UK endometrial ablation devices market, by technology type
6.3.2.3.2. UK endometrial ablation devices market, by end user
6.3.2.4. Italy
6.3.2.4.1. Italy endometrial ablation devices market, by technology type
6.3.2.4.2. Italy endometrial ablation devices market, by end user
6.3.2.5. Spain
6.3.2.5.1. Spain endometrial ablation devices market, by technology type
6.3.2.5.2. Spain endometrial ablation devices market, by end user
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe endometrial ablation devices market, by technology type
6.3.2.6.2. Rest of Europe endometrial ablation devices market, by end user
6.3.3. Europe endometrial ablation devices market, by technology type
6.3.4. Europe endometrial ablation devices market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan endometrial ablation devices market, by technology type
6.4.2.1.2. Japan endometrial ablation devices market, by end user
6.4.2.2. China
6.4.2.2.1. China endometrial ablation devices market, by technology type
6.4.2.2.2. China endometrial ablation devices market, by end user
6.4.2.3. Australia
6.4.2.3.1. Australia endometrial ablation devices market, by technology type
6.4.2.3.2. Australia endometrial ablation devices market, by end user
6.4.2.4. India
6.4.2.4.1. India endometrial ablation devices market, by technology type
6.4.2.4.2. India endometrial ablation devices market, by end user
6.4.2.5. South Korea
6.4.2.5.1. South Korea endometrial ablation devices market, by technology type
6.4.2.5.2. South Korea endometrial ablation devices market, by end user
6.4.2.6. Rest of Asia-Pacific
6.4.2.6.1. Rest of Asia-Pacific endometrial ablation devices market, by technology type
6.4.2.6.2. Rest of Asia-Pacific endometrial ablation devices market, by end user
6.4.3. Asia-Pacific endometrial ablation devices market, by technology type
6.4.4. Asia-Pacific endometrial ablation devices market, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil endometrial ablation devices market, by technology type
6.5.2.1.2. Brazil endometrial ablation devices market, by end user
6.5.2.2. Saudi Arabia
6.5.2.2.1. Saudi Arabia endometrial ablation devices market, by technology type
6.5.2.2.2. Saudi Arabia endometrial ablation devices market, by end user
6.5.2.3. South Africa
6.5.2.3.1. South Africa endometrial ablation devices market, by technology type
6.5.2.3.2. South Africa endometrial ablation devices market, by end user
6.5.2.4. Rest of LAMEA
6.5.2.4.1. Rest of LAMEA endometrial ablation devices market, by technology type
6.5.2.4.2. Rest of LAMEA endometrial ablation devices market, by end user
6.5.3. LAMEA endometrial ablation devices market, by technology type
6.5.4. LAMEA endometrial ablation devices market, by end user

CHAPTER 7: COMPANY PROFILES
7.1. AEGEA Medical, Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Product portfolio
7.1.4. Key strategic moves and developments
7.2. Boston Scientific Corporation
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. Hologic, Inc.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Idoman Teoranta
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Product portfolio
7.5. Medtronic Plc. (Smith & Nephew Plc.)
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Minerva Surgical, Inc.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product portfolio
7.6.4. Key strategic moves and developments
7.7. Olympus Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Omnitech Systems, Inc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.9. The Cooper Companies, Inc. (CooperSurgical, Inc.)
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Veldana Medical SA
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. product portfolio
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Endometrial Ablation Devices Market, by Technology and End User: Global Opportunity Analysis and Industry Forecast, 20182024" the market was valued at $882 million in 2017, and is expected to reach $1,299 million by 2024, growing at a CAGR of 5.6% from 2018 to 2024.

Endometrial ablation devices are used to remove the endometrium, which is the lining of the uterus. This procedure used for treatment of menorrhagia when it is not controlled with the help of medications. Increase in prevalence of menstrual disorders and rise in awareness about endometrial ablation devices majorly drive the growth of the endometrial ablation devices market. In addition, endometrial ablation offers some advantages, such as speed of treatment, efficiency, and minimal invasive procedure. These fuel the market growth globally.

Based on technology type, the market is segmented into radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon, hysteroscopic ablation, and others. At present, the radiofrequency ablation segment generates the major share of revenue due to speed of procedure and efficiency. On the other side, thermal balloon technology segment is anticipated to show the fastest growth during the forecast period primarily owning to its safety and procedure convenience.

Based on end user, the clinic segment occupied the largest share in 2017, and is anticipated to continue its dominance during the forecast period, due to availability of portable and easy to use endometrial ablation devices. However, the ambulatory surgery center segment is anticipated to exhibit the fastest market growth during the forecast period owing to a convenient environment as well as rise in number of ambulatory surgery centers.

Key findings of the Endometrial Ablation Devices Market:

Based on technology, the thermal balloon segment is expected to show the fastest market growth, at a CAGR of 6.8% from 2018 to 2024.
Based on technology, the radiofrequency ablation segment held more than one-third share in 2017 and is expected to remain dominant throughout the forecast period.
Based on end user, the ambulatory surgery segment exhibited fastest growth at a CAGR of 6.2% from 2018 to 2024.
Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.8% during the forecast period.

North America accounted approximately half in 2017 and is expected to remain dominant throughout the forecast period due to increase in awareness about endometrial ablation technology and rise in prevalence menorrhagia in the region, well-developed healthcare infrastructure, and strong presence of key players. On the other hand, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to surge in health care expenditure, rise in health awareness and increase in demand for minimally invasive procedures.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll